China Feihe IPO: Right Formula for Growth but There Could Be Risks
China Feihe (FEIHE HK), the largest domestic Infant Milk Formula (IMF) maker in China with a market share of 8.6% (in 2017) has filed for an IPO on...
871 Views
China Feihe IPO Preview: The Winning Formula?
China Feihe (FEIHE HK) is the leading player in the China IMF (infant milk formula) market as measured by retail sales value in 2018, according to...
603 Views
ECM Weekly (6 Jul 2019) - Budweiser APAC, Prime US REIT, Topsports, Douyu, JS Global, China Feihe
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
522 Views
China Feihe (中国飞鹤) IPO: New Numbers, New Red Flag, and Demographic Risk
China Feihe, a leading infant milk formula (IMF) manufacturer in China, is planning to raise up to USD 1 billion to list on the Stock Exchange of...
768 Views
ECM Weekly (23 March 2019) - ESR, Sun Car, Ruhnn, CanSino, Frontage, Wuxi Bio, WiseTech,
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
640 Views